title: A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma.
authors.affiliation: University Department of Clinical Oncology, Newcastle General Hospital, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Carmichael
authors.forename: B M
authors.initials: BM
authors.lastname: Cantwell
authors.forename: A L
authors.initials: AL
authors.lastname: Harris
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000188:drug therapy
chemical_list: D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide